Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by acrossthepondon Aug 27, 2019 3:36am
96 Views
Post# 30068632

RE:RE:RE:Ceo

RE:RE:RE:CeoThe absurdly long break in communications emanating from the company and now this recent squabble between directors which has resulted in resignations , and the somewhat “cheap” and inappropriate refurb bills outlined in the SEDAR document will have undermined all the earlier efforts the company has made to engender confidence with medical professionals, the investment establishment etc.....that they are potential (REALLY) big wheels in the medical device market . They had hitherto been very attentive in making info available promptly and clearly .....which had engendered some degree of confidence in their seriousness as businessmen and innovators. I’m afraid most of that has been lost. At fault is the CEO....Bakema. He should go surely so that a new CEO can rebuild the potential and make sure none of this nonsense happens again. Look out for further hard hitting incisive analysis of the situation to follow. 
Bullboard Posts